157 related articles for article (PubMed ID: 22195801)
1. Preparation and evaluation of injectable sustained-release microspheres of rivastigmine.
Zhu Y; Zhu Z; Cao Q; Chen D; Cui J
J Control Release; 2011 Nov; 152 Suppl 1():e131-2. PubMed ID: 22195801
[No Abstract] [Full Text] [Related]
2. Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.
Ye L; Fu F; Liu W; Sun K; Li Y; He J; Yu X; Yu P; Tian J
Pak J Pharm Sci; 2013 Mar; 26(2):315-22. PubMed ID: 23455202
[TBL] [Abstract][Full Text] [Related]
3. A study of rivastigmine liposomes for delivery into the brain through intranasal route.
Arumugam K; Subramanian GS; Mallayasamy SR; Averineni RK; Reddy MS; Udupa N
Acta Pharm; 2008 Sep; 58(3):287-97. PubMed ID: 19103565
[TBL] [Abstract][Full Text] [Related]
4. In situ-forming oleogel implant for rivastigmine delivery.
Vintiloiu A; Lafleur M; Bastiat G; Leroux JC
Pharm Res; 2008 Apr; 25(4):845-52. PubMed ID: 17694395
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
Chu DF; Fu XQ; Liu WH; Liu K; Li YX
Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971
[TBL] [Abstract][Full Text] [Related]
6. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
[TBL] [Abstract][Full Text] [Related]
7. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of rivastigmine liposome and its pharmacokinetics in rats after intranasal administration].
Yang ZZ; Wang ZZ; Wu K; Qi XR
Yao Xue Xue Bao; 2011 Jul; 46(7):859-63. PubMed ID: 22010358
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
10. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
[TBL] [Abstract][Full Text] [Related]
11. Monodisperse PLA/PLGA nanoparticle fabrication through a surfactant-free route.
Liang R; Zhu J
J Control Release; 2011 Nov; 152 Suppl 1():e129-31. PubMed ID: 22195799
[No Abstract] [Full Text] [Related]
12. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
Zhang H; Gao Y; Lv W; Jiao C; Duan M; Liu H; Han B
J Pharm Sci; 2011 Jul; 100(7):2790-800. PubMed ID: 21344412
[TBL] [Abstract][Full Text] [Related]
13. A facile way to fabricate polyester microcapsules.
Yu X; Zhu J
J Control Release; 2011 Nov; 152 Suppl 1():e128-9. PubMed ID: 22195798
[No Abstract] [Full Text] [Related]
14. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
[TBL] [Abstract][Full Text] [Related]
15. Long acting porous microparticle for pulmonary protein delivery.
Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Pollauf EJ; Kim KK; Pack DW
J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
[TBL] [Abstract][Full Text] [Related]
18. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
19. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
20. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
